UK markets closed
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,207.13 +444.10 (+2.50%) CRUDE OIL
78.93 -0.07 (-0.09%) GOLD FUTURES
2,317.20 +6.20 (+0.27%) DOW
38,192.55 +289.26 (+0.76%) Bitcoin GBP
47,389.46 +1,292.68 (+2.80%)
Arecor Therapeutics plc (AREC.L)
LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
At close: 09:19AM BST
Currency in GBp
Valuation measures4
| Market cap (intra-day) | 42.11M |
| Enterprise value | 34.05M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 12.34 |
| Price/book (mrq) | 3.19 |
| Enterprise value/revenue | 10.08 |
| Enterprise value/EBITDA | -3.57 |
Trading information
Stock price history
| Beta (5Y monthly) | -0.22 |
| 52-week change 3 | -49.07% |
| S&P500 52-week change 3 | 23.57% |
| 52-week high 3 | 280.00 |
| 52-week low 3 | 125.00 |
| 50-day moving average 3 | 138.64 |
| 200-day moving average 3 | 172.15 |
Share statistics
| Avg vol (3-month) 3 | 14.27k |
| Avg vol (10-day) 3 | 13.03k |
| Shares outstanding 5 | 30.63M |
| Implied shares outstanding 6 | 30.63M |
| Float 8 | 13.01M |
| % held by insiders 1 | 31.28% |
| % held by institutions 1 | 54.18% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in GBP.Fiscal year
| Fiscal year ends | 31 Dec 2022 |
| Most-recent quarter (mrq) | 30 Jun 2023 |
Profitability
| Profit margin | -278.81% |
| Operating margin (ttm) | -296.88% |
Management effectiveness
| Return on assets (ttm) | -34.01% |
| Return on equity (ttm) | -67.81% |
Income statement
| Revenue (ttm) | 3.38M |
| Revenue per share (ttm) | 0.11 |
| Quarterly revenue growth (yoy) | 140.80% |
| Gross profit (ttm) | N/A |
| EBITDA | -9.78M |
| Net income avi to common (ttm) | -9.42M |
| Diluted EPS (ttm) | -0.31 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 8.23M |
| Total cash per share (mrq) | 0.27 |
| Total debt (mrq) | 167k |
| Total debt/equity (mrq) | 1.26% |
| Current ratio (mrq) | 2.52 |
| Book value per share (mrq) | 0.43 |
Cash flow statement
| Operating cash flow (ttm) | -10.85M |
| Levered free cash flow (ttm) | -6.75M |
© 2024 Yahoo. All rights reserved.